Live
FierceBiotechMarch M&A surge triggers high expectations for 2026FierceBiotechBuoyed by $100M Series A, Stipple Bio debuts to advance lead oncology asset into clinicFierceBiotechHow ctDNA is redefining MRD monitoring in hematologic cancersEndpoints NewsNeurocrine will pay $2.9B for Soleno and its Prader-Willi medicineWatersQuilter Plc Has $13.04 Million Stock Holdings in Waters Corporation $WAT - MarketBeatThermo FisherThermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC - MarketBeatEndpoints NewsStipple Bio launches with $100M to find more precise targets on cancer proteinsEndpoints NewsChina's Syneron raises $150M for peptides, adding to last year's $100MBioPharma DivePerks persuade participantsAgilentAgilent unveils BioTek Cytation 9 Cell Imaging Multimode Reader - biospectrumasia.comThermo FisherThermo Fisher Microscopes: Precision in Scientific Imaging - AD HOC NEWS10x Genomics Blog10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance UK
BioWorld Mar 18, 2026

Shandong Xiansheng Maidejin Biological Pharmaceutical describes CDK4 inhibitors

Shandong Xiansheng Maidejin Biological Pharmaceutical describes CDK4 inhibitors

Original
Body unavailable. Use the original source.

Directory

59 All